Patents by Inventor Vikki Spaulding

Vikki Spaulding has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Human GIL-19/AE289 proteins
    Patent number: 8048984
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: December 1, 2008
    Date of Patent: November 1, 2011
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • COMPOSITION AND METHOD FOR TREATING INFLAMMATORY DISORDERS
    Publication number: 20110262390
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: May 23, 2011
    Publication date: October 27, 2011
    Applicant: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Method of treating psoriasis by administering IL-22 antibodies, or binding fragments thereof
    Patent number: 7951372
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Grant
    Filed: August 31, 2007
    Date of Patent: May 31, 2011
    Assignee: Wyeth LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Composition and Method for Treating Inflammatory Disorders
    Publication number: 20100260767
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: January 15, 2010
    Publication date: October 14, 2010
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Type 2 cytokine receptor and nucleic acids encoding same
    Publication number: 20090232809
    Abstract: The present invention provides novel isolated CRF2-13 polynucleotides and polypeptides encoded by the CRF2-13 polynucleotides. Also provided are the antibodies that immunospecifically bind to a CRF2-13 polypeptide or any derivative (including fusion derivative), variant, mutant or fragment of the CRF2-13 polypeptide, polynucleotide or antibody. The invention additionally provides methods in which the CRF2-13 polypeptide, polynucleotide and antibody are utilized in the detection and treatment of a broad range of pathological states, as well as to other uses.
    Type: Application
    Filed: September 18, 2008
    Publication date: September 17, 2009
    Inventors: Wei Liu, Lynette Fouser, Vikki Spaulding
  • Human GIL-19/AE289 proteins and polynucleotides encoding same
    Publication number: 20090227772
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Application
    Filed: December 1, 2008
    Publication date: September 10, 2009
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Human GIL-19/AE289 polynucleotides and methods of producing the encoded polypeptides
    Patent number: 7585646
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: September 8, 2009
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Human GIL-19/AE289 proteins
    Patent number: 7459533
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: December 17, 2004
    Date of Patent: December 2, 2008
    Assignee: Genetics Institute, LLC.
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Secreted proteins and polynucleotides encoding them
    Publication number: 20080139452
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Application
    Filed: December 13, 2007
    Publication date: June 12, 2008
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Kenneth Jacobs, John M. McCoy, Edward R. LaVallie, Lisa A. Collins-Racie, David Merberg, Michael J. Agostino, Robert Steininger, Vikki Spaulding, Gordon G. Wong, Hilary F. Clark, Kim Fechtel, Cheryl Evans, Maurice Treacy
  • Secreted proteins and polynucleotides encoding them
    Patent number: 7344861
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Grant
    Filed: April 3, 2006
    Date of Patent: March 18, 2008
    Assignee: Ono Pharmaceutical Co., Ltd.
    Inventors: Kenneth Jacobs, John M. McCoy, Edward R. LaVallie, Lisa A. Collins-Racie, David Merberg, Michael J. Agostino, Robert J. Steininger, II, Vikki Spaulding, Gordon G. Wong, Hilary F. Clark, Kim Fechtel, Cheryl Evans, Maurice Treacy
  • Human Gil-19/AE289 polynucleotides
    Patent number: 7307161
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Grant
    Filed: April 28, 2000
    Date of Patent: December 11, 2007
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Antibodies that bind to interleukin-22
    Patent number: 7279559
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Grant
    Filed: September 27, 2002
    Date of Patent: October 9, 2007
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Secreted proteins and polynucleotides encoding them
    Publication number: 20060269957
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Application
    Filed: July 12, 2006
    Publication date: November 30, 2006
    Applicant: Ono Pharmaceutical Co. Ltd.
    Inventors: Kenneth Jacobs, John McCoy, Edward LaVallie, Lisa Collins-Racie, Cheryl Evans, David Merberg, Maurice Treacy, Michael Bowman, Vikki Spaulding, McKeough Carlin-Duckett, Kerry Kelleher
  • Secreted proteins and polynucleotides encoding them
    Publication number: 20060177904
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Application
    Filed: April 3, 2006
    Publication date: August 10, 2006
    Applicant: ONO PHARMACEUTICAL CO., LTD.
    Inventors: Kenneth Jacobs, John McCoy, Edward LaVallie, Lisa Collins-Racie, David Merberg, Michael Agostino, Robert Steininger, Vikki Spaulding, Gordon Wong, Hilary Clark, Kim Fechtel, Cheryl Evans, Maurice Treacy
  • Secreted proteins and polynucleotides encoding them
    Publication number: 20060063227
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Application
    Filed: December 14, 2004
    Publication date: March 23, 2006
    Inventors: Kenneth Jacobs, John McCoy, Edward LaVallie, Lisa Collins-Racie, Cheryl Evans, David Merberg, Maurice Treacy, Michael Bowman, Vikki Spaulding, Michael Agostino
  • Secreted protein and polynucleotides encoding them
    Publication number: 20050250180
    Abstract: Novel polynucleotides and the proteins encoded thereby are disclosed.
    Type: Application
    Filed: October 22, 2003
    Publication date: November 10, 2005
    Inventors: Kenneth Jacobs, John McCoy, Edward LaVallie, Lisa Collins-Racie, Cheryl Evans, David Merberg, Maurice Treacy, Vikki Spaulding
  • Composition and method for trating inflammatory disorders
    Publication number: 20050238648
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Application
    Filed: June 20, 2005
    Publication date: October 27, 2005
    Inventors: Kenneth Jacobs, Debra Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Composition and method for treating inflammatory disorders
    Patent number: 6939545
    Abstract: Inhibitors of IL-22 are disclosed as well as pharmaceutical compositions and methods of using same. The inhibitors include IL-22 antibodies and are useful for treating inflammatory disorders.
    Type: Grant
    Filed: February 25, 2002
    Date of Patent: September 6, 2005
    Assignee: Genetics Institute, LLC
    Inventors: Kenneth Jacobs, Debra D. Pittman, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Human GIL-19/AE289 proteins and polynucleotides encoding same
    Publication number: 20050158760
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Application
    Filed: December 17, 2004
    Publication date: July 21, 2005
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan
  • Human GIL-19/AE289 proteins and polynucleotides encoding same
    Publication number: 20050153400
    Abstract: Novel human GIL-19/AE289 protein is disclosed which shows a high degree of homology to interleukin-10 (IL-10). Polynucleotides encoding such protein are also enclosed.
    Type: Application
    Filed: December 17, 2004
    Publication date: July 14, 2005
    Inventors: Kenneth Jacobs, Lynette Fouser, Vikki Spaulding, Dejun Xuan